T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.07M | ﹤0.01% |
5,087
+2,500
| +97% | +$519K |
|
|
QLIK
1677
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $1.06M | ﹤0.01% |
35,935
-150,255
| -81% | -$4.48M |
|
|
HIBB
1678
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.06M | ﹤0.01% |
30,435
| – | – |
|
|
DEL
1679
DELISTED
Deltic Timber
DEL
| $1.06M | ﹤0.01% |
15,730
-1,500
| -9% | -$95.1K |
|
1680
LXP Industrial Trust
LXP
$3.58B
| $1.05M | ﹤0.01% |
20,853
+2,203
| +12% | +$102K |
|
1681
Regal Rexnord
RRX
$11.4B
| $1.05M | ﹤0.01% |
19,144
+1,770
| +10% | +$106K |
|
1682
ATI
ATI
$30.9B
| $1.05M | ﹤0.01% |
82,082
+13,615
| +20% | +$195K |
|
|
NUVA
1683
DELISTED
NuVasive, Inc.
NUVA
| $1.05M | ﹤0.01% |
17,515
+35
| +0.2% | +$1.89K |
|
1684
Cinemark Holdings
CNK
$4.37B
| $1.04M | ﹤0.01% |
28,643
+2
| +0% | +$70 |
|
|
CSR
1685
Centerspace
CSR
$939M
| $1.04M | ﹤0.01% |
16,100
+804
| +5% | +$52.2K |
|
1686
Helix Energy Solutions
HLX
$1.49B
| $1.04M | ﹤0.01% |
153,510
-1,049,298
| -87% | -$7.59M |
|
|
AXLL
1687
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $1.03M | ﹤0.01% |
31,500
| – | – |
|
|
FMI
1688
DELISTED
Foundation Medicine, Inc.
FMI
| $1.02M | ﹤0.01% |
54,952
-18
| -0% | -$325 |
|
|
STOR
1689
DELISTED
STORE Capital Corporation
STOR
| $1.02M | ﹤0.01% |
34,711
+25,011
| +258% | +$659K |
|
|
TWO
1690
Two Harbors Investment
TWO
$1.26B
| $1.02M | ﹤0.01% |
14,874
+5,389
| +57% | +$355K |
|
|
PVTB
1691
DELISTED
PrivateBancorp Inc
PVTB
| $1.02M | ﹤0.01% |
23,105
+45
| +0.2% | +$1.83K |
|
1692
PENN Entertainment
PENN
$2.53B
| $1.01M | ﹤0.01% |
72,754
+23,800
| +49% | +$373K |
|
|
JCP
1693
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.01M | ﹤0.01% |
114,026
| – | – |
|
|
PPLI
1694
People Inc
PPLI
$3.01B
| $1.01M | ﹤0.01% |
100,499
-972,806
| -91% | -$9.01M |
|
|
MDP
1695
DELISTED
Meredith Corporation
MDP
| $1.01M | ﹤0.01% |
19,417
+27
| +0.1% | +$1.34K |
|
|
AHL
1696
DELISTED
ASPEN Insurance Holding Limited
AHL
| $1M | ﹤0.01% |
21,617
-4,050
| -16% | -$189K |
|
|
CSGS
1697
DELISTED
CSG Systems International
CSGS
| $999K | ﹤0.01% |
24,793
+3,782
| +18% | +$162K |
|
1698
Saic
SAIC
$5.35B
| $999K | ﹤0.01% |
17,118
+200
| +1% | +$10.9K |
|
|
IMI
1699
DELISTED
Intermolecular, Inc.
IMI
| $998K | ﹤0.01% |
674,200
+11,200
| +2% | +$22.6K |
|
|
CYS
1700
DELISTED
CYS Investments Inc.
CYS
| $998K | ﹤0.01% |
119,176
+18,443
| +18% | +$152K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.